Transglutaminase inhibitors
US4929630A · kind A · utility
26Cited by
7References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1989 |
| Grant date | May 29, 1990 |
| Priority date | — |
| Expiry date | Sep 8, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06191
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transglutaminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.